Merck & Company, Inc. (new) (MRK)
Today's Latest Price: $81.94 USD
Updated Dec 4 7:00pm
Add MRK to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
Merck & Co Inc (MRK) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering MRK.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 19 | $107 | $85 | $95.89 | $81.45 | 17.73% |
MRK Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.3 | 14 | 3 | 5 | 0 | 0 | 22 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- The percent of analysts bearish on the stock of MRK is lower than just about 100% of all US stocks.
- The number of analysts covering the stock of MRK is higher than 96.13% of Pharmaceutical Products stocks.
- The average analyst price target of MRK is greater than 90.67% of Pharmaceutical Products stocks.
- Merck & Co Inc's upside potential (average analyst target price relative to current price) is higher than 88.46% of stocks in the mega market cap category.
- Merck & Co Inc's variance in analysts' estimates is less than 86.54% of stocks in the mega market cap category.
- MRK has a greater percentage of analysts bullish on the stock than 69.23% of stocks in the mega market cap category.
- Merck & Co Inc's change in bullishness amongst analysts is less than just about 100% of all US stocks.
Stocks similar to Merck & Co Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ABBV, SRPT and SNY.
Make investment decisions regarding MRK using the data that counts. Try POWR Ratings for free.